GlassScriptPhysician profile
Jason S Bonslaver
NPI 1023269073
$1,244.64
in general payments reported to CMS, 2019-2025
16 companies · $39.45 in 2025
The $39.45 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.40 · 2020: $18.02 · 2021: $81.46 · 2022: $79.09 · 2023: $82.54 · 2024: $847 · 2025: $39.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $497 · Food and Beverage: $471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $497.26 |
| Food and Beverage | $471.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $750.89 | 2024 | Aquabeam System |
| Pfizer INC. | $85.46 | 2023-2024 | |
| Abbvie INC. | $68.23 | 2021-2023 | Lupron Depot |
| Astellas Pharma US INC | $48.87 | 2019-2021 | |
| Dentsply Ih Ab | $39.75 | 2024 | Lofric |
| Teleflex LLC | $39.45 | 2025 | Barrigel |
| C. R. Bard, INC. & Subsidiaries | $35.75 | 2019 | |
| Ambu INC. | $34.00 | 2021-2022 | |
| Rochester Medical Corporation | $31.77 | 2019 | |
| Sumitomo Pharma America, INC. | $22.93 | 2023 | Orgovyx |
| Myovant Sciences INC. | $21.20 | 2022 | |
| Allergan, INC. | $18.02 | 2020 | |
| Accord Healthcare, INC. | $17.52 | 2022 | |
| Tempus Ai, INC | $16.93 | 2024 | |
| Cook Medical LLC | $13.87 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$379.20 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Bonslaver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.